Vista Pharmaceuticals Share Price

Vista Pharmaceuticals

CMP as on04-Jul-22 15:21

₹ 7.00
-0.02 -0.28%


₹ 7.00

Turnover (lac)

₹ 1

Prev. Close

₹ 7.02

Day's Vol (shares)

₹ 6,341

Day's Range

₹ 6.75
₹ 7.24

Corporate Action

Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 25-Sep-2021 02-Sep-2021 - -
In Compliance with Regulation 34 of the SEBI (Listing Obligations & Disclosure Requirements) Regulation 2015 we herewith submit the 30th Annual Report for the Financial Year 2020-2021 along with Notice of the Annual General Meeting to be held on Saturday 25th day of September 2021 at 3.00 P.M through Video Conferencing (VC) /Other Audio Visual Means (OAVM) and the venue of meeting shall be deemed to be the registered office of the Company i.e. Plot Nos. 10 to 14 and 16 to 20 TSIIC Industrial Estate Gopalaipalli Village Narketpally Mandal Nalgonda District- 508254 Telangana. The Notice of AGM along with Annual report have been dispatched to the shareholders of the Company in compliance with the Circular No. 14/2020 dated April 08 2020 Circular No. 17/2020 dated April 13 2020 issued by the Ministry of Corporate Affairs followed by the Circular No. 20/2020 dated May 05 2020 and Circular No. 02/2021 dated January 13th 2021. Outcome/Proceedings - 30th Annual General Meeting of the Company held on Saturday 25th September 2021 at 03.00 P.M through video Conferencing (VC) / Other Audio Visual Means (OAVM). (As Per BSE Announcement Dated on 9/25/2021 4:17:24 AM) Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we write to inform you that the members of the Company have approved all the resolutions bearing item no. 1 & 2 contained in the Notice of 29th Annual General Meeting of the Company with requisite majority. The Company had appointed Mr. NVSS Suryanarayana Rao Company Secretary in practice as the Scrutinizer for remote e-voting and venue e-voting at the AGM. The Scrutinizer has submitted his report on 27th September 2021. In this connection we hereby enclose the consolidated results of the remote e-voting and venue e-voting at the Video Conferencing (VC) / Other Audio Visual Means (OAVM) meeting in the format prescribed together with the Scrutinizers Report. On the basis of the report received from the Scrutinizer the Company has declared that the Resolutions set out in the notice of 29th AGM were passed with requisite majority in favour of the Resolutions. Vista Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 9/27/2021 2:18:29 AM)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity